In addition, inhibiting the expression of TLR4, a receptor on microglia, reduces microglial activation and the release of inflammatory cytokines, including IL-6, TNF-α, and IL-1β, alleviating the chronic neuroinflammation associated with AD and other dementias [26]. Here, IL1B is linked to dementia.